With tightening regulations and rising costs, the pharmaceutical industry is being presented with a consistent challenge in the marketplace: Do more with less. As a result, pharma companies are reducing their internal capacities in manufacturing and R&D and are, instead, increasing their outsourcing.
More than ever, these companies are relying on external service providers to fulfill their manufacturing needs and improve their productivity. In 2016, a study from Industry Standard Research Reports revealed that life sciences companies now outsource two-thirds of their manufacturing activities to CMOs. That figure is even higher for small and mid-sized companies: up to 80% in 2015.
A good pharmaceutical CMO will solve problems, speed up time to market, increase efficiency and decrease costs. And while a large part of this effectiveness stems from choosing the right manufacturing partner with “best-fit” expertise, technology and capability, there’s one important aspect of the selection process that pharmaceutical companies are increasingly fixating on: customer service.
In a time when customers are better informed and have high expectations for product quality and support, pharmaceutical companies want partners who can provide great service to ensure maximum productivity and product success.
Click through to access the full whitepaper by Aphena Pharma Solutions here.
